רבלימיד 15 מ"ג

Ülke: İsrail

Dil: İbranice

Kaynak: Ministry of Health

Aktif bileşen:

LENALIDOMIDE 15 MG

Mevcut itibaren:

NEOPHARM SCIENTIFIC LTD

ATC kodu:

L04AX04

Farmasötik formu:

CAPSULES

Uygulama yolu:

PER OS

Tarafından üretildi:

CELGENE EUROPE LTD, UK

Terapötik grubu:

LENALIDOMIDE

Terapötik endikasyonlar:

1. Treatment of patients with transfusion-dependent anemia due to low- or intermediate - 1 - risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormality. 2. In combination with dexamethasone treatment of multiple myeloma patient who have received at least one prior therapy.

Yetkilendirme tarihi:

2009-04-01